{"name":"GlyPharma Therapeutics","slug":"glypharma-therapeutics","ticker":"","exchange":"","domain":"","description":"GlyPharma Therapeutics is a biotechnology company focused on the development of novel therapeutic peptides for gastrointestinal disorders. The company's lead candidates, FE203799 and its GLP-2 analogue, are currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNMnBYbi02YXg0OEFpTDFac3ZkSlk0WldPWjNLWTNXUk5udXlBZlNBMG50VWV6eTJibUhHdWNjRnUxN21TU1pNQmh4Rjlic29Tc3c2YXVqOTA2UHlpMFlVX0ZaNVIwVnRIOGhxbnpfTUlWSnhUQy1jdlN1b2RCYkI3RlR6QkVXVTBCRUgyam1ZOGw?oc=5","date":"2025-12-23","type":"pipeline","source":"The Business Journals","summary":"Boston biotech settles lawsuit alleging misappropriation of GLP-2 analog intellectual property - The Business Journals","headline":"Boston biotech settles lawsuit alleging misappropriation of GLP-2 analog intellectual property","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQaXFkb05VTnEzM1JSUEx0VGt1eHNnTTJNUW5oSmdJVVluNVI0SS1xdWhNTlhvX2lJWnBRc1NWRUlsRUpRb2J3X1FzLUFRb01MQWw1LU9kLVBKaGdYb0pTd2tsVjRnTTg0Z1U2cUxCTlNISWRXTG9tN0NoOFVSTmJKbjNDenU3bzM2Vmc?oc=5","date":"2025-11-11","type":"deal","source":"The Business Journals","summary":"Biotech acquired by Ironwood faces allegations of misappropriating trade secrets - The Business Journals","headline":"Biotech acquired by Ironwood faces allegations of misappropriating trade secrets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNNzRvd1ZnLW9tTTNJcnFKMExCTG40NGJRRGFGYkxiVWF6Z0JWcHZiNVVaMllfdnFSQjFaUS1VOXMxaWRRLWMtdjJQb2ExSE40VDNsVWpkYkEzNTcyTk05VUhHSnd0T0FRbGtoMzM4c0piTzcxQnNyX05rb2FfbWFOTWNiaFp6R3liYl9JczR2aHdjb29zc24xbDdZMTV6S1FFZk1xTTFQSldDVzZYMXJj?oc=5","date":"2018-10-09","type":"pipeline","source":"Fierce Biotech","summary":"Rare disease startup Therachon to absorb GLyPharma and its SBS candidate - Fierce Biotech","headline":"Rare disease startup Therachon to absorb GLyPharma and its SBS candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOa3BZc1ZLWDdZdXBuQUVJUV9oellLSkNJN09GN1U1X1hZRXRlMEtDOWRXcENaT2ZsUGM3UWlCQ2dnU2trcm84dWIxcjFsUXJMb3pJRGVGcENUdVBRcVpzdEdiTWNiR0RZSU80NHNqM2d5ZTVCTUZqcDI0M244R0lKWTdsR2g4TS1XMUxIU2NiRUNoVm1Sak53aUZJeWpnUGlCX1FENzgwWWhPQ0pKTFJrTDVoOGlWRVRrbjFIR1JWXzR2bDRkUks2MDkyanlRQWtUUTc4YVA3TTM?oc=5","date":"2018-10-09","type":"pipeline","source":"PR Newswire","summary":"Therachon Expands Rare Disease Pipeline with Acquisition of GLyPharma Therapeutic Inc. - PR Newswire","headline":"Therachon Expands Rare Disease Pipeline with Acquisition of GLyPharma Therapeutic Inc.","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}